Form 4 holding
Sr. VP and CFO
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,631
- Estimated value
- $7,770
- Report date
- 24 Aug 2025
- Price
- $2.14
- Ownership
- Direct
Gilad Mamlok - Sr. VP and CFO at Protalix BioTherapeutics, Inc.
Issuer-level insider activity
- Role
- Sr. VP and CFO
- Issuer ticker
- PLX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Gilad Mamlok since 05 Aug 2025
Reported holdings for Gilad Mamlok in Protalix BioTherapeutics, Inc.
Transaction history for Gilad Mamlok in Protalix BioTherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.